MMJ Phyto tech invests in Biologics Research Institute Australia

Company News

by Anna Napoli

Medical Canabis company, MMJ Phyto tech (ASX:MMJ) has invested $1 million dollars for a 16.7 per cent ownership stake in Biologics Research Institute Australia.

Biologics is the owner of Cannabis Access, a leading online portal for medical cannabis in Australia.

The service makes it easier for Doctors to access the appropriate type of the drug for their patients.

The portal provides and end-to end process for prescribing and accessing the drug.

The company says Cannabis Access is strongly positioned to address the challenges surrounding access to medical cannabis.

Shares in MMJ (ASX:MMJ) are trading flat at 36 cents.

Are you a 708 sophisticated investor?

A sophisticated investor is defined under Section 708 of the Corporations Act (net assets of $2.5 million or annual incomes in excess of $250,000).

They are eligible to receive information regarding wholesale investment opportunities that are not available to regular or retail investors.

Please subscribe if you would like to be alerted to these types of opportunities.